Insmed | INSM - Capitalisation Boursière

Prix De L'Action
135.17
Variation Quotidienne
-8.66 -6.02%
Mensuellement
-8.86%
Annuel
93.96%
Q2 Prévisions
132.28




Capitalisation Boursière Changement Date
BioMarin Pharmaceutical USD 11.42B 1.02B 2025-12
Cytokinetics USD 7.77B 1.19B 2025-12
DBV Technologies USD 274M 17M 2025-09
Gilead Sciences USD 166.62B 14.34B 2026-04
Heron Therapeutics USD 238M 7M 2025-12
Insmed USD 37.12B 6.68B 2025-12
Novartis USD 263.08B 17.01B 2025-12
Regeneron Pharmaceuticals USD 81.12B 21.53B 2025-12
Sarepta Therapeutics USD 2.26B 238M 2025-12
Ultragenyx Pharmaceutical USD 2.22B 680M 2025-12
Vertex Pharmaceuticals USD 115.03B 14.61B 2025-12